Want to join the conversation?
For FY17, $BF.A $BF.B expects cost increases to slightly increase more and offset the improvement through the price mix in the year. The company expects the SG&A cost containment effort to allow it to deliver leverage to the operating income line in FY17 resulting in 7-9% in underlying operating income.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?